Beyond Cancer Ltd., a subsidiary of Beyond Air Inc. (NASDAQ: XAIR), presented updated survival data from its Phase 1 trial ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE